Alphatec Holdings (ATEC) Total Debt Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Alphatec Holdings | 1.15 Bn | 1.01 Bn | 136.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.15% |
| Dec 31, 2025 | 68.10% |
| Sep 30, 2025 | 52.69% |
| Jun 30, 2025 | 121.46% |
| Mar 31, 2025 | 59.01% |
| Dec 31, 2024 | 60.60% |
| Sep 30, 2024 | 59.00% |
| Jun 30, 2024 | 119.08% |
| Mar 31, 2024 | 64.14% |
| Dec 31, 2023 | 62.76% |
| Sep 30, 2023 | 65.89% |
| Jun 30, 2023 | 65.40% |
| Mar 31, 2023 | 59.98% |
| Dec 31, 2022 | 54.75% |
| Sep 30, 2022 | 55.14% |
| Jun 30, 2022 | 51.90% |
| Mar 31, 2022 | 50.43% |
| Dec 31, 2021 | 47.89% |
| Sep 30, 2021 | 53.63% |
| Jun 30, 2021 | -2.44% |
| Mar 31, 2021 | 118.28% |
| Dec 31, 2020 | -12.07% |
| Sep 30, 2020 | 117.45% |
| Jun 30, 2020 | -32.92% |
| Mar 31, 2020 | -7.46% |
| Dec 31, 2019 | -8.19% |
| Sep 30, 2019 | -7.97% |
| Jun 30, 2019 | -33.11% |
| Mar 31, 2019 | -10.30% |
| Dec 31, 2018 | -2.12% |
| Sep 30, 2018 | -3.66% |
| Jun 30, 2018 | -2.44% |
| Mar 31, 2018 | -0.14% |
| Dec 31, 2017 | -0.29% |
| Sep 30, 2017 | 1.30% |
| Mar 31, 2017 | 7.07% |
| Dec 31, 2016 | 10.38% |
| Sep 30, 2016 | 4.06% |
| Jun 30, 2016 | 17.89% |
| Dec 31, 2015 | 18.60% |